Overall, we found that CD160, 2B4, TIGIT, and PD-1 expressing CD26lowCD8+ T cells were significantly enriched in CLL versus HCs (Fig. 2Y). This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.